Torcetrapib/atorvastatin: Phase III data

In the double-blind, U.S. and European Phase III ILLUSTRATE trial in 1,188 patients, torcetrapib/atorvastatin increased HDL-C and

Read the full 174 word article

How to gain access

Continue reading with a
two-week free trial.